ICU Medical just smashed Q2 earnings with $548 million in revenue, up 6% organically, and a robust 41% adjusted gross margin. Their core businesses—Consumables and IV Systems—are hitting record sales, with IV Systems soaring 13%. Despite currency headwinds in Latin America, North America drove the growth. The company is on track to hit its leverage target and has raised full-year guidance for EBITDA and EPS, fueled by lower tariffs and operational synergies. Investors are cheering as ICU Medical shows strong momentum and a clear path to exceed its annual goals.
Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN: advertise@thednn.ai
This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai.
Podden och tillhörande omslagsbild på den här sidan tillhör
The Daily News Now!. Innehållet i podden är skapat av The Daily News Now! och inte av,
eller tillsammans med, Poddtoppen.
